News

How Did Richard Ramirez Die? Here’s Why the Night Stalker's Demise Didn't Happen on Death Row 12 Years Ago
Serial killer Richard Ramirez died 12 years ago13. Here's everything to know about how Richard Ramirez, a.k.a. the so-called ...
Heidelberg Pharma to Present at the Life Sciences Virtual Investor Forum June 12th
Heidelberg Pharma AG (XETRA: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that Andreas Pahl, CEO of Heidelberg Pharma, will present ...
Marc Garneau died after 'short but very difficult battle' with cancer, former staffer says
Marc Garneau died this week after being diagnosed with two types of cancer earlier this year, his former staffer says.The ...
Seeking Alpha2d
AFMDQ Affimed N.V.
The company’s lead product candidates include AFM13 that has completed Phase 2 clinical trial for CD30-positive lymphoma, Phase Ib clinical trial for hodgkin lymphoma, and completed Phase IIb ...
Le Lézard3d
Circle Announces Pricing of Upsized Initial Public Offering
Circle Internet Group, Inc., a global financial technology company and stablecoin market leader, today announced the pricing of its upsized initial public offering of 34,000,000 shares of its Class A ...
Cancer still tops high-cost health claims but muscle and orthopedic conditions are making surprise surge: Sun Life report
WELLESLEY, Mass., June 4, 2025 /PRNewswire/ -- Sun Life, the nation's leading independent stop-loss provider for self-funded employers, today released its 13th annual high-cost claim and injectable ...
Le Lézard4d
BioVaxys Issues Corporate Update
BioVaxys Technology Corp. (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of current operating initiatives including the integration and disposition of assets acquired in ...
BIOVAXYS ANNOUNCES CONSOLIDATION AND CONCURRENT BROKERED PRIVATE PLACEMENT OFFERING FOR GROSS PROCEEDS OF UP TO $3,000,000
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces a proposed consolidation of the ...
PipelineReview.com11d
Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma
LADENBURG, Germany I May 27, 2025 I Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), ...
thederrick.com14d
Cities tied to George Floyd mark the 5th anniversary of his death
Religious services, concerts and vigils are scheduled to mark the fifth anniversary of George Floyd’s murder by a police officer in the cities where Floyd grew up and where he ...
Innate Pharma SA: Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides
Long term follow-up data from the TELLOMAK Phase 2 trial in Sézary syndrome (SS) and mycosis fungoides (MF) will be presented at the ASCO Annual Meeting 2025. Long-term follow-up data from ...
Light The Night shines bright thanks to Emerging Leaders
That’s what The Leukemia & Lymphoma Society (LLS) offers through Light The Night, a powerful community event series that ...